Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 41 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Low-dose radiopharmaceutical therapy enhances the efficacy of B7-H3 CAR T cells in murine metastatic neuroblastoma
    A. G. Shea, A. Ollendorff, A. Wilke +18
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. Biochemical and Mechanistic Characterization of the DNA-dependent Poly(ADP-ribose) Polymerase, MoPARP1, in Magnaporthe oryzae
    N. Payne, R. E. Kalicharan, A. Reyes-Kildare +1
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Resource limitation rewires chromosome instability and ploidy evolution across in vitro and in vivo cancer models
    T. Li, R. Beck, V. Tagal +2
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  4. In vivo intercellular CRISPR screens using viral proximity barcoding reveal regulators of tumor-immune interactions
    P. Du, S. Kohno, M. Wang +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. Vulnerability of triple negative breast cancer to daraxonrasib pan-RAS(on) inhibition
    M. P. East, J. F. Olivares-Quintero, D. O. Okumu +25
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  6. SRPK1 is a determinant of chemoresistance to Docetaxel in prostate cancer
    D. Duzgun, W. Read, S. Oltean
    bioRxivPreprintCC BYFull textOncologybioRxiv
  7. Oncogenic fusions induce an extensive cancer-restricted cryptic proteome in Ewing sarcoma
    L. A. Broeils, J. Pilet, M. K. Koshkina +38
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  8. A Tumor-Pituitary-Stromal Axis Promotes Colorectal Cancer Progression
    W. Li, S. Wang, H. Wu +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. RNA binding proteome profiling reveals RNA-dependent activation of oncogenic host signaling during KSHV infection.
    Yang Zhao, Xiang Ye, Madeline Yuen +3
    Nature communicationsPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Targeting Polθ Helicase with RP-3467: Preclinical Validation and Clinical Response in a gBRCA1 ovarian cancer patient with an acquired PARPi resistance mutation in TP53BP1
    A. Sfeir, E. Rosen, M.-C. Mathieu +29
    medRxivPreprintCC BYFull textOncologymedRxiv
  11. Validating LLM judges for automated oversight of patient communication
    Z. Xu, J. Zeng, S. Zhou +16
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  12. Population-Scale Precision Safety in Oncology Reveals Clinical and Genetic Determinants of Systemic Therapy Toxicity
    Z. Bakouny, X. A. Guo, F. Huang +34
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  13. Comparative evaluation of ChatGPT and gemini responses to patient-oriented questions on breast cancer
    Yeliz Yilmaz Bozok, Nihan Acar, Murat Kemal Atahan +1
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  14. From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells
    Esraa A. Salim, Xiaojia Ji, Michael Tarpley +4
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  15. A Review of Computational Modeling of Cancer Metastasis
    Romain Zakrajsek, David Boulate, Sébastien Benzekry
    HALPreprintCC BY-NC-SA 4.0Full textOncologyHAL
  16. Lumican - derived peptides inhibit melanoma cell growth and migration.
    Katarzyna Pietraszek-Gremplewicz, Stéphane Brézillon, Corinne Perreau +3
    PLoS ONEPeer-reviewedCC BY 4.0Full text65 citedOncologyPharmacology & toxicologyHAL
  17. Molecular Evolution of the Thermosensitive PAb1620 Epitope of Human p53 by DNA Shuffling
    Dimitris Xirodimas, David Lane
    Journal of Biological ChemistryPeer-reviewedCC BY25 citedOncologyHAL
  18. Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo
    Mark Saville, Alison Sparks, Dimitris Xirodimas +5
    Journal of Biological ChemistryPeer-reviewedCC BY158 citedOncologyHAL
  19. p14 Arf Promotes Small Ubiquitin-like Modifier Conjugation of Werners Helicase
    Yvonne Woods, Dimitris Xirodimas, Alan Prescott +3
    Journal of Biological ChemistryPeer-reviewedCC BY59 citedOncologyHAL
  20. Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5- and L11-dependent p53 Activation
    Xiao-Xin Sun, Yue-Gang Wang, Dimitris Xirodimas +1
    Journal of Biological ChemistryPeer-reviewedCC BYFull text80 citedOncologyHAL
  21. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation
    Nieves Embade, David Fernández-Ramos, Marta Varela-Rey +14
    HepatologyPeer-reviewedLicence not stated1 citedOncologyHAL
  22. Contextual assessment of perceived health system alignment with National Standards for Cancer Survivorship Care in the American Southeast
    Shirley M. Bluethmann, Stephanie Bunch, Chandylen Nightingale +9
    Journal of Cancer SurvivorshipPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  23. Neuropilin-1 is involved in lytic replication in a subset of primary effusion lymphoma cell lines and for KSHV gene expression in primary endothelial cells
    Anna K. P. Serquina, Julie Lee, Eric Cho +3
    mBioPeer-reviewedCC BYFull textOncologyPMC
  24. Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy
    Michael T. Sandholzer, Clara Serger, Alessia G. Liner +19
    Cell Reports MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  25. Benchmarking of bulk transcriptomic harmonization tools in a multi-platform B-cell lymphoma cohort identifies feature-specific quantile normalization and surrogate variable analysis as top-performing methods
    D. Nikitin, N. M. Borisov, M. Savchenko +9
    bioRxivPreprintCC BYFull text1 citedOncologybioRxiv